<DOC>
	<DOCNO>NCT00430989</DOCNO>
	<brief_summary>To investigate safety nitrous oxide ( N2O ) anaesthesia patient risk factor coronary artery disease undergo major surgery .</brief_summary>
	<brief_title>The ENIGMA II Trial : Nitrous Oxide Anaesthesia Cardiac Morbidity After Major Surgery : Randomised Controlled Trial</brief_title>
	<detailed_description>Approximately 25 % patient undergoing major surgery know coronary artery disease ( CAD ) risk factor CAD . N2O interfere vitamin B12 folate metabolism . This impairs production methionine ( homocysteine ) , use form tetrahydrofolate thymidine DNA synthesis . It repeatedly demonstrate N2O anaesthesia increase postoperative homocysteine level . Chronic hyperhomocysteinaemia associate cardiovascular disease , acute hyperhomocysteinaemia know cause endothelial dysfunction . One small trial demonstrate increased incidence postoperative myocardial ischaemia patient receive N2O anaesthesia . Reducing postoperative myocardial infarction death important aim CAD undergo major surgery . Our previous trial ( ENIGMA ) study 2050 patient identify serious adverse effect , patient risk CAD could reliably assess serious cardiac complication . We propose large simple randomized clinical trial 7,000 patient provide definitive evaluation safety N2O anaesthesia . Updated statistical analysis plan find www.enigma2.org.au .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Nitrous Oxide</mesh_term>
	<criteria>Inclusion Criteria 1 . Adult male female age ≥ 45 year , undergo noncardiac surgery general anaesthesia expect exceed two hour . 2 . At increase risk cardiac event , define 1. history coronary artery disease define history one following : i. angina ii . MI iii . segmental wall motion abnormality echocardiography fix defect radionuclide image iv . positive exercise stress test cardiac ischaemia v. positive radionuclide exercise , echocardiographic exercise , pharmacological cardiovascular stress test cardiac ischaemia vi . coronary revascularization ( CABG PTCA ) vii . angiographic evidence atherosclerotic stenosis &gt; 50 % diameter coronary artery viii . ECG pathological Q wave two contiguous lead 2. heart failure 3. cerebrovascular disease think due atherothrombotic disease 4. aortic peripheral vascular disease 5. three follow risk factor : age ≥70 year history congestive heart failure diabetes currently oral hypoglycaemic agent insulin therapy current treatment hypertension preoperative serum creatinine &gt; 175 micro mol/L ( &gt; 2.0 mg/dl ) current previous high cholesterol ≥6.2 mmol/L ( &gt; 240 mg/dl ) history transient ischemic attack ( TIA ) ( i.e . transient focal neurological deficit last less 24 hour think vascular origin ) emergency/urgent surgery ( i.e . surgery must undertake within 24 hour acute presentation hospital ) highrisk type surgery ( i.e . intrathoracic intraperitoneal ) Exclusion Criteria 1. cardiac surgery 2. mark impairment gasexchange expect require Fi02 &gt; 0.5 intraoperatively 3. specific circumstance N2O contraindicate ( eg . volvulus , pulmonary hypertension , raise intracranial pressure ) anaesthetist plan use supplemental oxygen ( eg . colorectal surgery ) 4 . N2O unavailable use .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Anaesthesia</keyword>
	<keyword>Major Surgery</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>Nitrous oxide</keyword>
	<keyword>Effects Nitrous Oxide follow Anaesthesia</keyword>
	<keyword>Anaesthesia coronary artery disease</keyword>
</DOC>